Condition: Refractory Metastatic Colorectal Cancer · Sponsor: Charite University, Berlin, Germany
Combined chemotherapy and radiofrequency electromagnetic field treatment for patients with liver dominant refractory metastatic colorectal cancer
This description comes directly from the study's public registry record.
Pirus Ghadjar, Prof. Dr. · +49 30 450 527318 · pirus.ghadjar@charite.de
Marcus Beck, Dr. · +49 30 450 527318 · marcus.beck@charite.de
Always discuss trial participation with your own doctor first.
| Charité Universitätsmedizin Berlin | Berlin, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05991102